A judge has signalled his intention to sign off on a $138 million settlement in a class action against IAG and approve a common fund order that gives the litigation funder a $34.5 million commission, but an application by the funder for reimbursement of after-the-event insurance has been refused.
The law firm behind a class action against German manufacturer 3A Composites over allegedly combustible cladding is seeking to add a new representative group member to cover the claims of owners of property with Alucobond panels.
A make-up artist has launched a Fair Work case against the ABC alleging she lost her shifts after refusing to wear a mask in the midst of the COVID-19 pandemic.
A Federal Court judge taking over a shareholder class action against IOOF Holdings from a recent High Court appointment has lamented the lack of progress in the case, which has been ongoing for nine months.
The consumer watchdog has launched enforcement action against Facebook, alleging the social media giant engaged in false, misleading or deceptive conduct in the promotion of its discontinued Onavo Protect mobile app.
Former BlueScope general manager of sales and marketing Jason Ellis has been sentenced to a wholly suspended prison term of eight months after pleading guilty to obstructing a price fixing investigation.
A partner bringing a $3.8 million age discrimination lawsuit against Deloitte Touche Tohmatsu will not seek to replead claims struck out earlier this month that the accounting giant made misrepresentations to Rio Tinto.
The Federal Court judge who is now overseeing a high stakes criminal cartel case against several investment banks and individuals over a $2.5 billion ANZ share placement has ordered that an indictment be filed by February 1, telling the parties “we have to get this case moving” and that he hoped to move the matter to trial “before we all retire”.
BHP Group Ltd has appealed a ruling allowing foreign group members to be part of a shareholder class action against the mining giant over the Fundao dam failure in Brazil five years ago.
Two units of US drug giant Johnson & Johnson have filed a lawsuit seeking preliminary discovery from Juno Pharmaceuticals for a possible patent lawsuit over a popular chemotherapy drug used to treat blood cancer.